Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock has moved higher by 10.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock opened at $6.12in last session, and closed at $6.27, while the day range of IDIX stock is $5.98 – $6.29. The stock showed a negative weekly performance of -9.52%.
Dendreon Corporation (NASDAQ:DNDN) has been got a patent (8,614,243) developed by Ofir Moreno, Seattle, Sateesh Natarajan, Bellevue, Wash., as well as David F. Duncan, San Diego, for “small-molecule modulators of Trp-p8 activity.” Dendreon Corporation (NASDAQ:DNDN) stock opened at $3.04, in last session and closed at $3.08, by gaining 1.32%. The 52 week range of the stock is $2.23 – $7.22. Company’s market capitalization is $485.06 billion.
Research analysts at Stifel Nicolaus upped their price objective on shares of NewLink Genetics Corp. (NASDAQ:NLNK) in a report released on Friday,AnalystRatings.NET reports. The firm currently has a “buy” rating on the stock. NewLink Genetics Corp (NASDAQ:NLNK) stock advanced 2.99% and finished the last session at $22.02. The EPS of the stock remained -1.23. Company’s market capitalization is $566.05 billion.
Anika Therapeutics, Inc. (NASDAQ:ANIK) reported strong quarterly results, with Q3 net income growing three-fold and revenue rising 20 percent over the year-ago quarter. Product gross margin for the third quarter of 2013 improved to 68% from 49% in the third quarter last year. Anika Therapeutics, Inc. (NASDAQ:ANIK) stock opened the session at $35.02, and closed the session at $34.35. The 52 week range of the stock remained $10.10 – $38.68 and the day range was $33.25 – $35.40.